YSYu Sun

Yu Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Sun has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Hao Wei

    West China School of Medicine, Sichuan University, Chengdu, China

    2 shared publications
  • Haokun Wu

    Radiotherapy Physics & Technology Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Hexiang Feng

    West China Medical School, Sichuan University/West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Jiang Zhu

    Department of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu 610041, China

    2 shared publications
  • Linjun Zhong

    Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Mei Li

    Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications

Latest Publications

  • Open Access

    Application of productive failure theory combined with debriefing teaching model in peripherally inserted central catheter skill training for oncology specialist nurses

    by Zhiying Yue, Haokun Wu, Linjun Zhong, Mingxia Li, Mingli Zeng, Yujiao Zeng, Hexiang Feng, Rujun Zheng, Yu Sun

    Based on the limitations of the traditional model of PICC skills training for domestic oncology specialist nurses in terms of curriculum design, training effect and clinical application, This study explored the application of the productive failure theory combined with debriefing in teaching peripherally inserted central catheter skills to oncology specialist nurses. This quasi-experimental study was conducted in 2023 and involved 146 oncology nurses recruited from Sichuan Province. Participants were assigned to either the control group (n = 73) or the intervention group (n = 73) based on the principle of baseline comparability and convenience sampling. The control group received traditional teaching method, whereas the intervention group underwent a combined repeated teaching approach grounded in the theory of productive failure. Before the training intervention, the demographic characteristics, professional theoretical knowledge, professional operation skills, learning motivation, clinical thinking ability, problem solving ability, self-efficacy, test scores and subjective evaluation in general information has no significant difference between the two groups (P > 0.05), which was comparable. After the intervention, the scores of the above five items and the teaching satisfaction of the intervention group were significantly higher than those of the control group, and the difference was statistically significant (P < 0.05). In the skill teaching of central venous catheter through peripheral puncture, the teaching mode based on productive failure theory combined with debriefing teaching is obviously superior to the traditional teaching mode, which can significantly enhance the professional knowledge, skills, learning motivation, critical thinking, self-efficacy and other comprehensive qualities of oncology specialist nurses. It is worthy of being further incorporated into futher clinical content teaching research.


  • Open Access

    Lycium barbarum-probiotic synergy alleviates chemotherapy-induced cancer-related fatigue via gut microbiota-metabolic axis regulation in mice

    by Hexiang Feng, Linjun Zhong, Xinjian Yang, Haokun Wu, Qiankai Sun, Hao Wei, Yinbo He, Linsen Zhou, Yusong Zhang, Mei Li, et al.

    Introduction: This study investigated the effects of a compound preparation combining Lycium barbarum and probiotics (LB-Pro) on chemotherapy-induced cancer-related fatigue (CRF) in a murine model. The aim was to explore potential mechanisms related to the gut microbiota-metabolic axis.Materials and methods: A CRF model was established in C57BL/6NCr mice using 5-fluorouracil. Mice were divided into four groups receiving varying concentrations of LB-Pro. Over 14 days, interventions were administered, followed by treadmill exhaustion tests to assess fatigue levels. Body weight, serum biomarkers (TNF-α, GSH-Px, NAD-MDH, SOD), and gut microbiota composition were analyzed to evaluate physiological and metabolic changes.Results: Administration of medium- and high-concentration LB-Pro significantly improved fatigue-related outcomes, including prolonged exhaustion times and enhanced antioxidant enzyme activities, compared to the control group. Low-concentration LB-Pro showed limited efficacy. Gut microbiota analysis revealed alterations in microbial composition, including enrichment of short-chain fatty acid-producing taxa, and metabolic pathways associated with energy metabolism and antioxidant defense were upregulated in probiotic-treated groups.Conclusion: LB-Pro alleviated chemotherapy-induced CRF in mice, likely through modulation of gut microbiota and enhancement of mitochondrial energy metabolism and antioxidant systems. These findings highlight the potential of integrative approaches combining traditional Chinese medicine and probiotics for managing CRF, emphasizing the gut microbiota-metabolic axis as a key therapeutic target.


  • Open Access

    Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo‐controlled study

    by Hao Wei, Zhiying Yue, Jialong Han, Ping Chen, Ke Xie, Yu Sun, Jiang Zhu

    Background: Chemotherapy is an important approach for lung cancer patients. The study was designed to evaluate the feasibility of the compound probiotic supplements in improving the quality of life for lung cancer patients undergoing chemotherapy.Methods: This randomized, double‐blind, placebo‐controlled trial enrolled chemotherapy‐naive patients with lung cancer who were scheduled to receive platinum‐based doublet chemotherapy. All eligible patients were randomly administered (1:1) compound probiotic supplements (group BP‐1) or placebo (group C) for two chemotherapy cycles. The EORTC QLQ C30 questionnaire scores were evaluated before the first, second, and third cycles of chemotherapy. The primary endpoint was the difference in the EROTC QLQ C30 questionnaire score between the two groups after two cycles of chemotherapy.Results: A total of 110 patients were recruited from March 2021 to January 2022. After undergoing two cycles of chemotherapy, group BP‐1 were significantly better in various dimensions of the overall quality of life, role function, nausea and vomiting, appetite loss, constipation, and diarrhea relative to group C (76.90 ± 18.31 vs. 58.89 ± 17.17; 93.33 ± 11.58 vs. 85.93 ± 15.06; 0.00 ± 0.00 vs. 27.04 ± 29.15; 6.67 ± 13.53 vs. 22.22 ± 18.80; 0.95 ± 5.63 vs. 28.15 ± 22.42; 2.86 ± 9.47 vs. 15.56 ± 16.82; p < 0.05, respectively). The incidence of nausea and vomiting, appetite loss, constipation, and diarrhea in group BP‐1 was significantly lower than in group C (0% vs. 71.43%, 16.67% vs. 57.14%, 2.38% vs. 63.27%, and 7.14% vs. 42.86%, respectively, p < 0.001).Conclusions: Compound probiotic supplements can improve the quality of life and relieve chemotherapy‐related gastrointestinal side effects for lung cancer patients receiving platinum‐based doublet chemotherapy. (Chinese Clinical Trial Registry: ChiCTR1800019269).


  • Open Access

    Diverse gut microbiota pattern between mild and severe cancer‐related fatigue in lung cancer patients treated with first‐line chemotherapy: A pilot study

    by Hao Wei, Lingling Xie, Yihan Zhao, Jun He, Jiang Zhu, Mei Li, Yu Sun

    Background: Cancer survivors perceive cancer‐related fatigue (CRF) as one of the most common symptoms. However, the potential relationship between CRF and gut microbiota has not been elucidated. Our study aimed to preliminary explore the diverse gut microbiota composition between mild and severe CRF in advanced lung cancer patients undergoing first‐line chemotherapy.Methods: A total of 20 advanced lung patients treated with first‐line chemotherapy were enrolled, 10 with mild CRF and 10 with severe CRF. The self‐reported Piper Fatigue Scale and stool samples were collected from all eligible patients. The 16 S ribosomal ribonucleic acid gene was performed to analyze the intestinal microbiome.Results: We identified the significantly diverse gut microbiota composition among patients with mild and severe CRF. The pattern was characterized by the increasing abundance in short‐chain fatty acid‐producing taxa for mild CRF patients (genus Lachnospiraceae‐UCG‐008 and family Lachnospiraceae, p < 0.05), whereas higher abundance in taxa related to inflammation (family Enterobacteriaceae and genus Escherichia‐Shigella, p < 0.05) for severe CRF patients. Significantly different Kyoto Encyclopedia of Genes and Genomes pathways between mild and severe CRF patients were evaluated concerning fatty acid metabolism, nucleotide metabolism, brain function, amino acid metabolism, and so on (p < 0.05).Conclusions: Our study observed a plausible association between different levels of CRF and the diverse gut microbiota composition, with increasing proinflammation taxa in severe CRF patients and anti‐inflammation taxa growing in mild CRF patients. Further studies are warranted to evaluate whether CRF can be improved by modulating the gut microbiota composition.